Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT04268199

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

Led by AHS Cancer Control Alberta · Updated on 2025-12-15

100

Participants Needed

2

Research Sites

339 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is to see if the standard of care subcutaneous injection of bortezomib can safely be administered at home by the patient or caregiver. All tests and assessments are based on standard of care procedures.

CONDITIONS

Official Title

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients are aged 18 years old or older with a diagnosis of symptomatic myeloma
  • Stable clinical status as deemed by responsible investigator
  • Personally (or caregiver) willing and deemed capable to self-administer with teaching
  • Previously received more than 4 injections of bortezomib within the hospital and/or cancer centre environment
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Currently participating in clinical trials that includes the use of bortezomib
  • History of allergic reactions to bortezomib
  • History of bleeding attributable to bortezomib
  • History of greater than or equal to grade 3 side effects attributable to bortezomib
  • Clinically deemed unlikely to be compliant with therapy by responsible investigator
  • Life expectancy anticipated to be less than 6 months
  • Deemed geographically inaccessible to receive care

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Arthur J.E. Child Comprehensive Cancer Centre

Calgary, Alberta, Canada, T2N 5G2

Actively Recruiting

2

Cross Cancer Institute

Edmonton, Alberta, Canada, T6G 1Z2

Actively Recruiting

Loading map...

Research Team

J

Jason Tay, MD

CONTACT

A

Amy Abel

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here